Upload
yepa
View
61
Download
2
Embed Size (px)
DESCRIPTION
Supplementary Figure S3. Analysis of mTOR and AKT signaling in breast cancer cell lines treated with dasatinib and rapamycin. MCF7. MDA-MB-231. BT474. 1hr. 24hr. 1hr. 24hr. 1hr. 24hr. Combo. Combo. Combo. Combo. Combo. Combo. DMSO. DMSO. DMSO. DMSO. DMSO. DMSO. Rap. - PowerPoint PPT Presentation
Citation preview
Supplementary Figure S3
p-Src
t-Src
t-AKT
p-AKT
p-p70S6K
t-p70S6K
p-S6
t-S6
β-actin
p-Fox01/3a
DMSO Das Rap
Combo01234
p:t-
AKT
DMSO Das Rap
Combo01234
DMSO
Das Rap
Com
bo
DMSO
Das Rap
Com
bo
1hr 24hr
MCF7
DMSO Das Rap
Combo0123456
DMSO Das Rap
Combo0123456
DMSO
Das Rap
Com
bo
DMSO
Das Rap
Com
bo
1hr 24hr
MDA-MB-231
DMSO Das Rap
Combo0
0.51
1.52
2.53
DMSO Das Rap
Combo0
1
2
3
DMSO
Das Rap
Combo
DMSO
Das Rap
Combo
1hr 24hr
BT474
Analysis of mTOR and AKT signaling in breast cancer cell lines treated with dasatinib and rapamycin